The control of dopamine neuron development, function and survival: Insights from transgenic mice and the relevance to human disease

被引:33
作者
Eells, JB [1 ]
机构
[1] NIDDKD, NIH, Bethesda, MD 20892 USA
关键词
dopamine neurotransmission; transgenic mice; knockout mice;
D O I
10.2174/0929867033457700
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transgenic technology, especially the use of homologous recombination to disrupt specific genes to produce knockout mice, has added considerably to the understanding of dopamine (DA) neuron develop survival and function. The current review summarizes results from knockout mice with the target disruption of genes involved in the development of DA neurons (engrailed I and 2, 1mx1b, and Nurr1), in 4 maintaining DA neurotransmission (tyrosine hydroxylase, vesicular monoamine transporter, DA transporter, DA D2 and D3 receptors) and important for DA neuron survival (alpha-synuclein, glia cell line-derived neurotrophic factor and superoxide dismutase). As alterations in DA neurotransmission have been implicated in a number of human neuropathologies including Parkinson's disease, schizophrenia and attention deficit/hyperactivity disorder, understanding how specific genes are involved in the function of DA neurons and the compensatory changes that result from loss or reduction in gene expression could provide important insight for the treatment of these diseases.
引用
收藏
页码:857 / 870
页数:14
相关论文
共 163 条
  • [91] Maruyama K, 1998, INT J ONCOL, V12, P1237
  • [92] Environmental risk factors and Parkinson's disease: Selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat
    McCormack, AL
    Thiruchelvam, M
    Manning-Bog, AB
    Thiffault, C
    Langston, JW
    Cory-Slechta, DA
    Di Monte, DA
    [J]. NEUROBIOLOGY OF DISEASE, 2002, 10 (02) : 119 - 127
  • [93] BIOCHEMICAL DEFECT OF THE HPH-1 MOUSE MUTANT IS A DEFICIENCY IN GTP-CYCLOHYDROLASE ACTIVITY
    MCDONALD, JD
    COTTON, RGH
    JENNINGS, I
    LEDLEY, FD
    WOO, SLC
    BODE, VC
    [J]. JOURNAL OF NEUROCHEMISTRY, 1988, 50 (02) : 655 - 657
  • [94] MEIERGERD SM, 1993, J NEUROCHEM, V61, P764
  • [95] Mena MA, 1997, J NEUROCHEM, V69, P21
  • [96] Mercuri NB, 1997, NEUROSCIENCE, V79, P323
  • [97] Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease
    Mezey, E
    Dehejia, AM
    Harta, G
    Suchy, SF
    Nussbaum, RL
    Brownstein, MJ
    Polymeropoulos, MH
    [J]. MOLECULAR PSYCHIATRY, 1998, 3 (06) : 493 - 499
  • [98] Alpha synuclein in neurodegenerative disorders: Murderer or accomplice?
    Mezey, E
    Dehejia, A
    Harta, G
    Papp, MI
    Polymeropoulos, MH
    Brownstein, MJ
    [J]. NATURE MEDICINE, 1998, 4 (07) : 755 - 757
  • [99] MILLEN KJ, 1994, DEVELOPMENT, V120, P695
  • [100] Dopamine receptors: From structure to function
    Missale, C
    Nash, SR
    Robinson, SW
    Jaber, M
    Caron, MG
    [J]. PHYSIOLOGICAL REVIEWS, 1998, 78 (01) : 189 - 225